What’s new in the field of prostate cancer chemoprevention?

Kanwaljit Mahal, Javier Hernandez, Joseph W. Basler, Ian M. Thompson

Producción científica: Articlerevisión exhaustiva

Resumen

Chemoprevention trials for several malignancies are completed, planned, or underway. Prostate cancer is one of the most common forms of cancer and understandably has received considerable recent attention as a potential target for chemoprevention. This article examines chemoprevention trials for prostate cancer, including the Prostate Cancer Prevention Trial, Selenium and Vitamin E Cancer Prevention Trial, and cyclooxygenase inhibitors in the prevention of prostate cancer.

Idioma originalEnglish (US)
Páginas (desde-hasta)177-182
Número de páginas6
PublicaciónCurrent urology reports
Volumen6
N.º3
DOI
EstadoPublished - jun 2005

ASJC Scopus subject areas

  • Urology

Huella

Profundice en los temas de investigación de 'What’s new in the field of prostate cancer chemoprevention?'. En conjunto forman una huella única.

Citar esto